109322 ⎘
Active agents used in cell culture processes, e.g. differentation; Cytokines; Chemokines; Interleukins [IL] Interleukin-7 (IL-7)
CELLS EXPRESSING ANTIGEN- & SEQUENCE-SPECIFIC T-CELL RECEPTORS (TCRS) AND METHODS OF MAKING THE SAME USING ENFORCED TCR GENE REARRANGEMENT
#2METHOD FOR GENERATING NK CELLS
#3IMMUNE CELL ORGANOID CO-CULTURES
#4GRID-FREE METHODS FOR MAKING GAMMA DELTA T CELLS
#5MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF
#6CELL SIGNALING COMPLEXES AND USES THEREOF
#7PEPMIXES TO GENERATE MULTIVIRAL CTLS WITH BROAD SPECIFICITY
#8SERUM-FREE MEDIA FORMULATION FOR CULTURING CELLS AND METHODS OF USE THEREOF
#9METHOD OF DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO HEMATOPOIETIC PRECURSOR AND STEM CELLS
#10GENERATION OF CD4 T CELLS
#11ACTIVATION AND PROLIFERATION OF CYTOTOXIC LYMPHOCYTES
#12PROCESSES FOR GENERATING ENGINEERED CELLS AND COMPOSITIONS THEREOF
#13UROLITHINS AND T-CELL MEDIATED IMMUNE RESPONSE
#14METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
#15METHODS FOR GENERATING GAMMA DELTA T-CELLS AND RELATED COMPOSITIONS
#16PROCESS FOR T CELL EXPANSION
#17CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#18METHODS FOR PRODUCING CELL POPULATIONS WITH INCREASED NUCLEIC ACID UPTAKE
#19CHIMERIC COSTIMULATORY RECEPTORS, CHEMOKINE RECEPTORS, AND THE USE OF SAME IN CELLULAR IMMUNOTHERAPIES
#20CULTURE MEDIUM COMBINATION FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CD34+ HEMATOPOIETIC STEM/PROGENITOR CELLS
#21METHODS OF T CELL DIFFERENTIATION AND COMPOSITIONS THEREOF
#22METHODS FOR CULTURING CELLS
#23GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#24COMPOSITION AND METHOD FOR EX VIVO EXPANSION OF STEM CELL MEMORY T CELLS
#25Remnant Tumor Infiltrating Lymphocytes and Methods of Preparing and Using the Same
#26PROCESS FOR OBTAINING FUNCTIONAL LYMPHOCYTES CELLS
#27SERUM-FREE FORMULA FOR T CELL EXPANSION
#28COMPOSITIONS AND METHODS FOR DIFFERENTIATING STEM CELLS INTO NK CELLS
#29ENGINEERED STEM CELLS AND USES THEREOF
#30USE OF MEMORY LYMPHOCYTE POPULATION IN LIVER CANCER TREATMENT
#31RECOMBINANT PRODUCTION OF GROWTH FACTORS IN ALGAE FOR CELL CULTURE APPLICATIONS
#32COMPOSITIONS AND METHODS FOR NK CELL DIFFERENTIATION
#33METHODS OF GENERATING T-CELLS FROM STEM CELLS AND IMMUNOTHERAPEUTIC METHODS USING THE T-CELLS
#34A METHOD FOR PRODUCING iPS CELL-DERIVED NATURAL KILLER CELLS
#35METHOD OF PREPARING AND EXPANDING A POPULATION OF IMMUNE CELLS FOR CANCER THERAPY, POTENCY ASSAY FOR TUMOR RECOGNITION, BIOLOGICAL VACCINE PREPARATION AND EPITOPETARGET FOR ANTIBODIES
#36INSULIN TREATMENT TO IMPROVE T CELL ENGINEERING
#37VIRAL-BINDING PROTEIN AND RELATED REAGENTS, ARTICLES, AND METHODS OF USE
#38CLEAVAGE RESISTANT CD16 CONSTRUCTS AND USES THEREOF
#39METHODS FOR STIMULATING AND TRANSDUCING T CELLS
#40IL7-IL15 TxM Compositions and Methods
#41T Cells
#42METHOD AND KIT FOR PREPARING AN IMMUNE CELL DIFFERENTIATED FROM A STEM CELL
#43IDENTIFICATION, IN VITRO AMPLIFICATION, AND APPLICATION METHOD OF MEMORY CD8 T CELLS SPECIFIC FOR TUMOR ANTIGEN
#44CELLULAR MICROCOMPARTMENTS COMPRISING LYMPHOCYTES FORMING A 3D GROUPED CULTURE AND HAVING A LOW GRANZYME B CONTENT
#45METHOD OF USING FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS TO INCREASE COLLAGEN AND ELASTIN IN HUMAN SKIN
#46METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF IMMUNE CELLS
#47METHOD FOR PREPARING T CELLS FOR ADOPTIVE T CELL THERAPY
#48CELLULAR MICROCOMPARTMENTS COMPRISING LYMPHOCYTES FORMING A GROUPED 3D CULTURE AND HAVING A LOW TNF ALPHA CONTENT
#49CYTOKINE RECEPTOR AGONIST AND VIRAL VECTOR COMBINATION THERAPIES
#50MANUFACTURING PROCESSES FOR ADOPTIVE CELL THERAPIES
#51NATURAL KILLER CELLS PRODUCED FROM INDUCED PLURIPOTENT STEM CELLS, METHOD FOR PRODUCING SAME, AND USE THEREOF
#52GENETICALLY ENGINEERED T CELL FOR CELL THERAPY
#53T CELL MANUFACTURING COMPOSITIONS AND METHODS
#54T CELL PRODUCTION METHOD
#55METHOD TO GENERATE MORE EFFICIENT CAR-T CELLS
#56EFFICIENT TCR GENE EDITING IN T LYMPHOCYTES
#57SYSTEMS, APPARATUSES, AND METHODS FOR CELLULAR THERAPEUTICS MANUFACTURE
#58PROCESS FOR GENERATING THERAPEUTIC COMPOSITIONS OF ENGINEERED CELLS
#59METHODS OF MANUFACTURING ALLOGENEIC CAR T CELLS
#60MODIFIED INVARIANT NATURAL KILLER T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
#61METHOD FOR DIFFERENTIATING HEMATOPOIETIC STEM/PROGENITOR CELLS INTO NK CELLS
#62STAGED CULTURE METHOD FOR IN-VITRO EXPANSION OF HUMAN CYTOKINE-INDUCED KILLER (CIK) AND USE THEREOF
#63METHODS FOR THE PRODUCTION OF TCR GAMMA DELTA + T CELLS
#64Methods for Activation and Expansion of T Cells
#65NUCLEIC ACID MODIFIED BIOLOGICAL CELL WITH EXPANSION-DEPENDENT GENE EXPRESSION
#66RIC cell and preparation method therefor and use thereof
#67PRODUCTION METHOD FOR NATURAL KILLER CELLS
#68MEDIUM COMPOSITION FOR INDUCING DIFFERENTIATION FROM PLURIPOTENT STEM CELLS INTO NATURAL KILLER CELLS AND DIFFERENTIATION METHOD USING SAME
#69METHODS OF MANUFACTURING CELLULAR COMPOSITIONS
#70EXPANSION OF HUMAN GROUP 2 INNATE LYMPHOID CELLS AND METHODS OF USE THEREOF
#71METHOD OF PRODUCING A POPULATION OF IMMUNE CELLS FROM PLURIPOTENT STEM CELLS
#72METHOD OF PRODUCING NATURAL KILLER CELLS AND COMPOSITION FOR TREATING CANCER
#73LABEL-FREE CELL ISOLATION
#74PHENOTYPIC MARKERS FOR CELL THERAPY AND RELATED METHODS
#75T CELL PROGENITOR HAVING CONTROLLED EXPRESSION OF A TRANSGENE OF INTEREST
#76A METHOD FOR INDUCING IPSC DIFFERENTIATION TO OBTAIN CD34+CELLS AND NK CELLS AND APPLICATION THEREOF
#77METHODS OF ASSESSING POTENCY OF VIRAL VECTORS
#78TRANSGENIC T CELL RECEPTORS TARGETING NEOANTIGENS FOR DIAGNOSIS, PREVENTION, AND/OR TREATMENT OF HEMATOLOGICAL CANCERS
#79MIR155 AS THE INTEGRATION SITE TO OVERCOME ACUTE GRAFT VERSUS HOST DISEASE OF GENE-MODIFIED IMMUNE EFFECTOR CELLS
#80IN VITRO EXPANSION METHOD FOR CULTIVATING MEMORY IMMUNE CELL
#81Rapid T-Cell Manufacturing
#82SORTING WITH COUNTER SELECTION USING SEQUENCE SIMILAR PEPTIDES
#83LARGE-SCALE EXPANSION OF ENGINEERED HUMAN GAMMA DELTA T CELLS
#84T CELL IMMUNOTHERAPY DERIVED FROM HIGHLY FUNCTIONAL AUTOLOGOUS STEM CELL MEMORY T CELLS
#85Cell signaling complexes and uses thereof
#86METHODS OF PREPARING T CELLS FOR T CELL THERAPY
#87METHODS FOR MANUFACTURING T CELLS EXPRESSING OF CHIMERIC ANTIGEN RECEPTORS AND OTHER RECEPTORS
#88METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#89COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC T CELL EXPANSION
#90IMMUNE CELL POPULATIONS AND USES THEREOF
#91METHODS FOR IMPROVING THE EFFICACY AND EXPANSION OF CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#92MATERIALS AND METHODS FOR ENHANCED STEM-CELL LIKE MEMORY T CELL ENGINEERING
#93VIRUS-SPECIFIC IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS
#94NOVEL PEPTIDES & COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML & OTHER CANCERS
#95Culture Medium and Culture Method for Human Primary Acute Myeloid Leukemia Cells
#96METHODS OF T CELL PRODUCTION
#97TUMOR INFILTRATION LYMPHOCYTE CULTURE MEDIUM AND APPLICATION THEREOF
#98COLD ATMOPSHERIC PLASMA TREATED PAN-CANCER EPITOPE PEPTIDE WITHIN THE COLLAGEN TYPE VI A-3 (COL6A3) PROTEIN AS CANCER VACCINE
#99GENERATION OF T CELL LINES WITH SPECIFICITY AGAINST ONE OR MORE NEOANTIGENS
#100METHOD FOR PRODUCING DIRECTLY REPROGRAMMED NATURAL KILLER CELLS AND USES THEREOF
#101METHODS AND COMPOSITIONS FOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS AND DERIVED NATURAL KILLER CELLS
#102METHOD FOR PRODUCING CD8alpha+beta+ CYTOTOXIC T CELLS
#103PRODUCTION OF ENGINEERED T CELLS FROM STEM CELLS
#104METHODS FOR CULTURING CELLS
#105METHOD FOR GENERATING PROGENITOR T CELLS FROM STEM AND/OR PROGENITOR CELLS AND USE OF SAME
#106COMPOSITIONS AND METHODS FOR DIFFERENTIATING AND EXPANDING B LINEAGE CELLS
#107SARS-COV-2-SPECIFIC T CELLS AND METHODS OF TREATMENT USING THEM
#108T CELLS COMPRISING AN UNREARRANGED T CELL RECEPTOR (TCR) GENE LOCUS AND METHODS OF USE THEREOF
#109MODULATED IMMUNODOMINANCE THERAPY
#110GENERATING CIK NKT CELLS FROM CORD BLOOD
#111METHOD FOR PRODUCING HEMATOPOIETIC CELLS FROM STEM CELLS USING VASCULAR ORGANOIDS
#112GENERATION OF T-CELLS BY DIRECT REPROGRAMMING FROM FIBROBLASTS AND MSC
#113METHODS FOR ACTIVATION AND EXPANSION OF NATURAL KILLER CELLS AND COMBINATIONS WITH BISPECIFIC ANTIBODIES
#114STROMA-FREE NK CELL DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS
#115TISSUE-SPECIFIC ANTIGENS FOR CANCER IMMUNOTHERAPY
#116METHOD FOR ACTIVATING T CELLS FOR CANCER TREATMENT
#117Compositions and Methods for Genetically Modifying CIITA in a Cell
#118METHODS FOR CULTURING CELLS
#119METHODS OF PRODUCING HAEMOGENIC ENDOTHELIAL CELLS FROM PLURIPOTENT STEM CELLS
#120USE OF IL-7R-ALPHA-GAMMA AGONIST PEPTIDES IN CELL MANUFACTURING
#121METHODS OF ACTIVATING T CELLS
#122METHODS OF PREPARING AND EXPANDING TYPE I INNATE LYMPHOID CELLS AND THERAPEUTIC USES THEREOF
#123RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS WITH CD14 PROMOTER AND USE THEREOF
#124CAR T CELL THERAPIES WITH ENHANCED EFFICACY
#125ARTIFICIAL ANTIGEN-PRESENTING CELL
#126METHODS FOR PREPARING TUMOR-INFILTRATING LYMPHOCYTES
#127METHOD FOR DIFFERENTIATING PLURIPOTENT STEM CELL-DERIVED HEMOGENIC ENDOTHELIAL CELLS INTO LYMPHOID LINEAGE CELLS
#128NANOPARTICLE-MEDIATED IMMUNE CELL MANUFACTURE AND USE THEREOF
#129COMPOSITIONS, CONSTRUCTS AND VECTORS FOR CELL REPROGRAMMING
#130METHODS OF PREPARING T CELLS FOR T CELL THERAPY
#131KSHV ONCOPROTEIN ANTIGENS AND EPITOPES FOR EXPANDING ANTIGEN-SPECIFIC T CELLS
#132INDUCIBLE PLURIPOTENT STEM CELL DERIVED REGENERATIVE T CELLS
#133METHODS OF PREPARING LYMPHOCYTES FOR CELL THERAPY
#134RAS NEOANTIGENS AND USES THEREOF
#135ANTI-VIRAL CENTRAL MEMORY CD8+ VETO CELLS IN HAPLOIDENTICAL STEM CELL TRANSPLANTATION
#136CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTIGEN BINDING DOMAIN SPECIFIC FOR MSLN HAVING A SPECIFICITY FOR TUMOR CELLS
#137VETO CELLS GENERATED FROM MEMORY T CELLS
#138GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#139METHODS AND MATERIALS FOR EXPANDING ANTIGEN-SPECIFIC T CELLS IN CULTURE
#140HUMAN INNATE LYMPHOID CELL PRECURSORS: IDENTIFICATION, CHARACTERIZATION, APPLICATIONS
#141METHODS FOR CULTURING CELLS EXPRESSING C-JUN
#142METHODS FOR CULTURING CELLS EXPRESSING ROR1-BINDING PROTEIN
#143MPC INHIBITION FOR PRODUCING T-CELLS WITH A MEMORY PHENOTYPE
#144UNIVERSAL ANTIGEN-SPECIFIC T CELL BANKS AND METHODS OF MAKING AND USING THE SAME THERAPEUTICALLY
#145METHOD FOR GENERATING T CELLS PROGENITORS
#146METHODS AND COMPOSITIONS FOR TREATING CANCER
#147COLD PLASMA TREATMENT MEDIATED TUMOR SPECIFIC T CELL THERAPY
#148PHARMACEUTICAL COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE
#149COMPOSITIONS AND METHODS OF GENERATING AN IMMUNE RESPONSE
#150SEED CELL MEDIUM OF TUMOR-INFILTRATING LYMPHOCYTE AND APPLICATION THEREOF
#151METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
#152METHOD FOR OBTAINING CAR-NK CELLS
#153SARS-COV-2-SPECIFIC T CELLS
#154IMMUNOTHERAPY FOR POLYOMAVIRUSES
#155PROCESS FOR PRODUCING DONOR-BATCHED CELLS EXPRESSING A RECOMBINANT RECEPTOR
#156METHOD TO PRODUCE T CELLS AND USES THEREOF
#157ANTIGEN PRESENTING T CELLS, SENSITIZED, MANUFACTURED T CELLS AND METHODS OF TREATMENT USING THE SAME
#158T CELL PROGENITOR PRODUCTION METHOD
#159T CELL RECEPTOR RECOGNISING KRAS MUTATION AND ENCODING SEQUENCE THEREOF
#160CHIMERIC ANTIGEN RECEPTORS TARGETING CD33
#161LONG LIVED T CELLS FOR TREATING HIV INFECTION
#162T CELL COMPOSITIONS FOR IMMUNOTHERAPY
#163NATURAL KILLER CELLS AND ILC3 CELLS AND USES THEREOF
#164GENERATION OF AUTOIMMUNE INHIBITORY T CELLS BY FIBROBLAST MEDIATED EDUCATION
#165GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#166Remnant tumor infiltrating lymphocytes and methods of preparing and using the same
#167Compositions and methods for differentiating stem cells into NK cells
#168Efficient TCR gene editing in T lymphocytes
#169METHODS OF PRODUCING T CELL POPULATIONS USING INDUCED PLURIPOTENT STEM CELLS
#170METHOD OF PRODUCING TUMOR-REACTIVE T CELL COMPOSITION USING MODULATORY AGENTS
#171EXPANSION OF NATURAL KILLER CELLS AND ILC3 CELLS WITH NOVEL AROMATIC COMPOUNDS
#172Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
#173Method for Preparing CD7-Negative, CD3-Positive T Cells
#174ENHANCEMENT OF iPSC-DERIVED EFFECTOR IMMUNE CELL USING SMALL COMPOUNDS
#175METHOD OF GENERATION OF LYMPHO-MYELOID NICHES
#176NATURAL KILLER CELLS
#177T-CELL MASTER CELL BANK
#178METHOD FOR PRODUCING T CELLS
#179MEDIA FORMULATIONS AND METHODS FOR PRODUCING PROGENITOR T CELLS
#180UNIVERSAL CAR-T CELL AND PREPARATION AND USE THEREOF
#181GENERATION OF CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FROM STEM CELLS AND THERAPEUTIC USES THEREOF
#182METABOLISM GUIDES DEFINITIVE LINEAGE SPECIFICATION DURING ENDOTHELIAL TO HEMATOPOIETIC TRANSITION
#183Generating CIK NKT cells from cord blood
#184Method for ex vivo expansion CD34+HSPCs into NK cells using an aryl hydrocarbon receptor antagonist
#185COMPOSITION FOR CULTURING PERIPHERAL BLOOD MONOCYTE-DERIVED REGULATORY T CELL AND REGULATORY T CELL CULTURING METHOD USING SAME
#186Compositions and Methods for Generating Alpha-Beta T Cells from Induced Pluripotent Stem Cells
#187SYSTEMS, APPARATUSES, AND METHODS FOR CELLULAR THERAPEUTICS MANUFACTURE
#188Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#189METHODS FOR PRODUCING CELL POPULATIONS WITH INCREASED NUCLEIC ACID UPTAKE
#190GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
#191METHODS OF ISOLATING T CELL POPULATIONS
#192CULTURE MEDIUM FOR HAEMATOPOIETIC INDUCTION
#193POPULATIONS OF NATURAL KILLER CELLS COMPRISING A CD38 CHIMERIC ANTIGEN RECEPTOR
#194FOXP3 ENGINEERED CD4+ T CELLS FOR USE IN TREG-BASED IMMUNOTHERAPY
#195METHODS OF PRODUCING HAEMOGENIC PROGENITOR CELLS FROM PLURIPOTENT STEM CELLS
#196ORDERED PROCESSING OF BLOOD PRODUCTS TO PRODUCE THERAPEUTICALLY ACTIVE CELLS
#197POPULATIONS OF NATURAL KILLER CELLS FOR TREATING CANCERS
#198ENGINEERED OFF-THE-SHELF IMMUNE CELLS AND METHODS OF USE THEREOF
#199ANTIGEN-SPECIFIC T CELL BANKS AND METHODS OF MAKING AND USING THE SAME THERAPEUTICALLY
#200Pepmixes to generate multiviral CTLS with broad specificity
#201LOW DENSITY CELL CULTURE
#202VIRUS-LIKE PARTICLE
#203CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS TARGETING ALK
#204MULTIPLE ANTIGEN SPECIFIC CELL THERAPY METHODS
#205METHODS FOR GENERATION OF TUMOR ORGANOID-FISHED T CELLS AND IDENTIFICATION OF ANTI-TUMOR T CELL RECEPTORS
#206Method for Generation of Genetically Modified T Cells
#207ENGINEERED GAMMA DELTA T CELLS AND METHODS OF MAKING AND USING THEREOF
#208MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#209Compositions and methods for differentiating stem cells into NK cells
#210METHOD FOR PRODUCING CAR GENE-INTRODUCED NK CELLS AND USE THEREOF
#211EX VIVO METHODS FOR PRODUCING A T CELL THERAPEUTIC AND RELATED COMPOSITIONS AND METHODS
#212COMPOSITION, CULTURE MEDIUM AND METHOD FOR INDUCING AND/OR AMPLIFYING TSCM IN VITRO
#213METHODS FOR CULTURING IMMUNE CELLS
#214MULTI-RESPIRATORY VIRUS ANTIGEN-SPECIFIC T CELLS AND METHODS OF MAKING AND USING THE SAME THERAPEUTICALLY
#215METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#216METHOD FOR PRODUCING IMMUNOCYTES, AND USE THEREOF
#217METHOD FOR EXPANSION AND DIFFERENTIATION OF T LYMPHOCYTES AND NK CELLS FOR ADOPTIVE TRANSFER THERAPIES
#218Recombinant adeno-associated virus vectors with CD14 promoter and use thereof
#219EX VIVO GENERATION OF GAMMA DELTA FOXP3+ REGULATORY T CELLS AND THERAPEUTIC USES THEREOF
#220NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS
#221Methods or generating T-cells from stem cells and immunotherapeutic methods using the T-cells
#222Genetically modified anti-third party central memory T cells and use of same in immunotherapy
#223NATURAL KILLER CELLS
#224CAR NK cells
#225MEDIA AND METHODS FOR DIFFERENTIATING NATURAL KILLER CELLS
#226IMMUNE CELL FUNCTION
#227FACTOR RICH PRODUCTS FROM UMBILICAL CORD MESENCHYMAL STEM CELLS
#228ACCELERATED HUMAN HEMATOPOEITIC STEM CELL DIFFERENTIATION TOWARDS MATURE NATURAL KILLER CELLS WITH ENHANCED ANTIBODY-DEPENDENT CYTOTOXIC ACTIVITY
#229PERSONALIZED NEOANTIGEN-SPECIFIC ADOPTIVE CELL THERAPIES
#230METHODS FOR SELECTION AND STIMULATION OF CELLS AND APPARATUS FOR SAME
#231HIGH-EFFICIENCY METHOD FOR PRODUCING GENETICALLY MODIFIED CELLS
#232GENERATING HPV ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION
#233Methods for the production of TCR gamma delta + t cells
#234Methods for the production of TCR gamma delta + T cells
#235GENERATION OF HOXA-EXPRESSING HEMOGENIC ENDOTHELIUM WITH ENHANCED T CELL POTENTIAL FROM HPSCS
#236FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS
#237Pepmixes to generate multiviral CTLs with broad specificity
#238METHOD FOR INDUCING AND DIFFERENTIATING PLURIPOTENT STEM CELLS AND USES THEREOF
#239METHODS FOR CULTURING CELLS
#240Process for generating genetically engineered autologous T cells
#241METHOD FOR PRODUCING CD3-POSITIVE CELL
#242METHOD FOR PRODUCING NATURAL KILLER CELLS FROM PLURIPOTENT STEM CELLS
#243Mycobacterial antigen compositions and methods of use
#244IL7-IL15 TxM Compositions and Methods
#245METHODS OF OBTAINING A MIXED POPULATION OF HUMAN XCR1+ AND PLASMACYTOID DENDRITIC CELLS FROM HEMATOPOIETIC STEM CELLS
#246GENERATING VIRUS OR OTHER ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION
#247Methods for improving the efficacy and expansion of immune cells
#248USE OF MEMORY LYMPHOCYTE POPULATION IN LIVER CANCER TREATMENT
#249UMBILICAL CORD LINING STEM CELLS AND CONDITIONED MEDIA THEREOF
#250CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#251Veto cells generated from memory T cells
#252METHOD FOR PREPARING CHIMERIC ANTIGEN RECEPTOR T CELLS BY SERUM-FREE CULTURE
#253IMMUNE CELL ORGANOID CO-CULTURES
#254SERUM-FREE MEDIA FORMULATION FOR CULTURING CELLS AND METHODS OF USE THEREOF
#255CAR-CD30 T cells for treatment of CD30+ tumors
#256Generating CIK NKT cells from cord blood
#257Remnant tumor infiltrating lymphocytes and methods of preparing and using the same
#258Method of manufacturing dual specific T-cells for use in cancer immunotherapy
#259Method for generating T cell progenitors
#260Method for generating T cells progenitors
#261PROCESSES FOR GENERATING ENGINEERED CELLS AND COMPOSITIONS THEREOF
#262Generating HPV antigen-specific cells from a naive T cell population
#263T lymphocyte production methods and t lymphocytes produced thereby
#264COMPOSITIONS CONTAINING A CELL PRODUCT COMPRISING AN EXPANDED AND ENRICHED POPULATION OF SUPERACTIVATED CYTOKINE KILLER T CELLS AND METHODS FOR MAKING SAME
#265Generating HPV antigen-specific cells from a naive T cell population
#266Antigen-specific T cells and uses thereof
#267Phenotypic markers for cell therapy and related methods
#268Remnant tumor infiltrating lymphocytes and methods of preparing and using the same
#269TRANSPOSON SYSTEM AND METHODS OF USE
#270Human innate lymphoid cell precursors: identification, characterization, applications
#271CBL inhibitors and compositions for use in adoptive cell therapy
#272NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS
#273CBL INHIBITORS AND COMPOSITIONS FOR EXPANSION OF IMMUNE CELLS
#274Method for preparing CAR-T cell with TCM as main active component and use thereof
#275EX VIVO NK CELL DIFFERENTIATION FROM CD34+ HEMATOPOIETIC CELLS
#276CAR T CELL THERAPIES WITH ENHANCED EFFICACY
#277Method of producing natural killer cells and composition for treating cancer
#278Method for reconstructing immune function using pluripotent stem cells
#279METHODS FOR MANUFACTURING T CELLS
#280Multiple antigen specific cell therapy methods
#281Methods for directed differentiation of pluripotent stem cells to immune cells
#282METHODS OF PRODUCING CELLS EXPRESSING A RECOMBINANT RECEPTOR AND RELATED COMPOSITIONS
#283Method for activating T cells for cancer treatment
#284METHODS OF TREATING HEMATOLOGICAL DISORDERS, SOLID TUMORS, OR INFECTIOUS DISEASES USING NATURAL KILLER CELLS
#285Methods for manufacturing T cells by direct sorting and compositions thereof
#286Methods and Compositions for Modulating TH-GM Cell Function
#287METHOD FOR PRODUCING NATURAL KILLER CELL AND USE THEREOF
#288Method for generating T cells progenitors
#289Process for generating therapeutic compositions of engineered cells
#290METHOD FOR ACTIVATING HELPER T CELL
#291Methods of manufacturing allogeneic CAR T cells
#292NATURAL KILLER CELLS AND USES THEREOF
#293Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#294Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#295Method for activating T cells for cancer treatment
#296METHODS FOR DIRECTED DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO HLA HOMOZYGOUS IMMUNE CELLS
#297Methods for selectively expanding cells expressing a TCR with a murine constant region
#298Methods and compositions for inducing hematopoietic cell differentiation
#299Methods and materials for expanding antigen-specific T cells in culture
#300T CELL COMPOSITIONS FOR IMMUNOTHERAPY